These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10885058)

  • 1. Potentiality of proton nuclear magnetic resonance and multivariate calibration methods for the determination of dermatan sulfate contamination in heparin samples.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Analyst; 2000 May; 125(5):933-8. PubMed ID: 10885058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
    Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
    Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
    Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.
    McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A
    Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance spectra of heparin in admixture with dermatan sulfate and other glycosaminoglycans. 2-D spectra of the chondroitin sulfates.
    Holme KR; Perlin AS
    Carbohydr Res; 1989 Mar; 186(2):301-12. PubMed ID: 2500236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the composition of heparin mixtures from various origins using proton nuclear magnetic resonance and multivariate calibration methods.
    Ruiz-Calero V; Saurina J; Galceran MT; Hernández-Cassou S; Puignou L
    Anal Bioanal Chem; 2002 Jul; 373(4-5):259-65. PubMed ID: 12110977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
    Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
    Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of chondroitin sulfate and dermatan sulfate in danaparoid sodium by (1)H NMR spectroscopy and PLS regression.
    Ustün B; Sanders KB; Dani P; Kellenbach ER
    Anal Bioanal Chem; 2011 Jan; 399(2):629-34. PubMed ID: 20862579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
    Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
    J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic and electrophoretic applications for the analysis of heparin and dermatan sulfate.
    Malsch R; Harenberg J; Piazolo L; Huhle G; Heene DL
    J Chromatogr B Biomed Appl; 1996 Oct; 685(2):223-31. PubMed ID: 8953163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
    Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
    J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.
    Norwig J; Beyer T; Brinz D; Holzgrabe U; Diller M; Manns D
    Pharmeur Sci Notes; 2009 Mar; 2009(1):17-24. PubMed ID: 19275869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE.
    Zhang Z; Li B; Suwan J; Zhang F; Wang Z; Liu H; Mulloy B; Linhardt RJ
    J Pharm Sci; 2009 Nov; 98(11):4017-26. PubMed ID: 19642166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative 2D 1H, 13C HSQC NMR Spectroscopy for the Determination of Chondroitin Sulfate and Dermatan Sulfate Content in Danaparoid Sodium.
    Gardini C; Boccardi G; Guerrini M; Kellenbach E; Lunenburg M; van der Meer JY; Naggi A; Urso E
    Thromb Haemost; 2023 Sep; 123(9):856-866. PubMed ID: 37094794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of dermatan sulfate active site for heparin cofactor II by 1H nuclear magnetic resonance spectroscopy.
    Mascellani G; Liverani L; Prete A; Bergonzini G; Bianchini P; Torri G; Bisio A; Guerrini M; Casu B
    Anal Biochem; 1994 Nov; 223(1):135-41. PubMed ID: 7695089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved impurity fingerprinting of heparin by high resolution (1)H NMR spectroscopy.
    Bigler P; Brenneisen R
    J Pharm Biomed Anal; 2009 May; 49(4):1060-4. PubMed ID: 19211212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-dimensional cellulose acetate plate electrophoresis--a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharmaceutical heparin.
    Domanig R; Jöbstl W; Gruber S; Freudemann T
    J Pharm Biomed Anal; 2009 Jan; 49(1):151-5. PubMed ID: 19062213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (1)H NMR signal at 2.10 ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach.
    Kellenbach E; Sanders K; Michiels PJ; Girard FC
    Anal Bioanal Chem; 2011 Jan; 399(2):621-8. PubMed ID: 21069304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method.
    Bednarek E; Sitkowski J; Bocian W; Mulloy B; Kozerski L
    J Pharm Biomed Anal; 2010 Nov; 53(3):302-8. PubMed ID: 20417048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.